Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Dawnrays Pharmaceutical Holdings Ltd. ( (HK:2348) ) has shared an announcement.
Dawnrays Pharmaceutical Holdings Ltd. has announced a board meeting scheduled for August 22, 2025, to review and approve the interim results for the first half of the year ending June 30, 2025. The meeting will also consider the declaration of an interim dividend, reflecting the company’s ongoing financial assessment and potential shareholder returns.
More about Dawnrays Pharmaceutical Holdings Ltd.
Dawnrays Pharmaceutical Holdings Ltd. is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. The company focuses on the development, manufacture, and sale of pharmaceutical products, serving various market needs.
Average Trading Volume: 2,115,131
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$2.04B
See more data about 2348 stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money